1,274 results

Filter

More filter Other Filter Icon

Search Export

Purulent acute otitis media in children over 3 months

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 14/5/2025

Add to my selection
Human papillomavirus vaccination: extension of the catch-up vaccination cohort to men and women up to and including 26 years of age

Vaccine recommendation - Posted on 13/5/2025

Download practice guideline

Add to my selection
Purulent acute otitis media in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Acute nasopharyngitis and acute strep throat in children

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Acute nasopharyngitis and acute strep throat in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Adult sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Paediatric sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Acute simple cystitis, cystitis with risk of complication or recurrent cystitis in women

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Acute pyelonephritis in women

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
Pregnant women - urinary colonisation and cystitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025

Add to my selection
See 35 result in Practice Guidelines and Other Guides

IMFINZI

Medicine - Posted on 1/12/2025

Add to my selection
IMBRUVICA

Medicine - Posted on 1/12/2025

Add to my selection
RINVOQ

Medicine - Posted on 1/12/2025

Add to my selection
REBLOZYL (luspatercept)

Medicine - Posted on 1/12/2025

Add to my selection
LORAZEPAM XILMAC (lorazépam)

Medicine - Posted on 1/12/2025

Add to my selection
DARZALEX

Medicine - Posted on 21/11/2025

Add to my selection
ADEMPAS

Medicine - Posted on 21/11/2025

Add to my selection
BRAFTOVI - MEKTOVI (encorafenib, binimetinib)

Medicine - Posted on 21/11/2025

Add to my selection
JEMPERLI (dostarlimab)

Medicine - Posted on 21/11/2025

Add to my selection
TEVIMBRA (tislélizumab)

Medicine - Posted on 21/11/2025

Add to my selection
See 1234 result in Drugs, devices and medical acts

Early access to medicinal products

Web page - Posted on 1/7/2021 - Mis à jour le 7/11/2025

Add to my selection
Early access authorisation : a positive initial report and refined assessment methods

Press release - Posted on 20/5/2022

Add to my selection
The HAS medication action plan: a first positive assessment is drawn

Press release - Posted on 19/6/2020

Add to my selection
Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

Press release - Posted on 28/6/2019 - Mis à jour le 13/2/2020

Add to my selection
HAS unveils its action plan for innovative medicines

Press release - Posted on 27/1/2020

Add to my selection
See 5 result in Articles and news

My account

You do not have a saved search

No element in selection

1,274 results

Practice guidelines and other guides - 35 results

Purulent acute otitis media in children over 3 months

Human papillomavirus vaccination: extension of the catch-up vaccination cohort to men and women up to and including 26 years of age

Purulent acute otitis media in adults

Acute nasopharyngitis and acute strep throat in children

Acute nasopharyngitis and acute strep throat in adults

Adult sinusitis

Paediatric sinusitis

Acute simple cystitis, cystitis with risk of complication or recurrent cystitis in women

Acute pyelonephritis in women

Pregnant women - urinary colonisation and cystitis

Drugs, devices and medical acts - 1,234 results

IMFINZI

IMBRUVICA

RINVOQ

REBLOZYL (luspatercept)

LORAZEPAM XILMAC (lorazépam)

DARZALEX

ADEMPAS

BRAFTOVI - MEKTOVI (encorafenib, binimetinib)

JEMPERLI (dostarlimab)

TEVIMBRA (tislélizumab)

Articles and news - 5 results

Early access to medicinal products

Early access authorisation : a positive initial report and refined assessment methods

The HAS medication action plan: a first positive assessment is drawn

Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

HAS unveils its action plan for innovative medicines

Follow us :